Biomarin Pharmaceutical (US09061G1013)

MK:Large Cap
Z-Score:4.33
F-Score:5
Symbol:BMRN
Index:
Sector:Healthcare
Industry:Biotechnology & Drugs
Chart: onvista.de

Levermann-Analysis Sell

CriterionValuePoint
1. Return on Equity CY20.92 %1
2. EBIT-Margin CY-1.98 %-1
3. Equity Ratio CY70.21 %1
4. P/E ratio 5Y88.55-1
5. P/E ratio CY-181.63-1
6. Analyst opinions1.27-1
7. Reaction to quarterly figures-2.04 %-1
8. Profit revision 2021 : -34.38 %
2022 : -20.72 %
-1
9. Price today vs. Price 6 months ago2.83 %0
10. Price today vs. Price 1 year ago-17.66 %-1
11. Price momentumFactor 9: 0
Factor 10: -1
0
12. Three-month-reversalFeb: Performance < NASDAQ 100-Perf.
Mar: Performance < NASDAQ 100-Perf.
Apr: Performance < NASDAQ 100-Perf.
1
13. Profit growth304.65 %1
-3
Sorry Altman analysis not avilable for this stock

Point history



Dieser Inhalt ist nur für Premium-Mitglieder abrufbar.


Login Registration